Top Highlights for Sep 2015:
- Dr Reddy's signs In-Licensing deal worth US$ 60 Million+Milestones+Royalties with Hatchtech of Australia.
- IP rights of Australia based Alchemia's Fondaparinux to be bought by Dr Reddy's for USD 17.5 million.
- India based Transasia buys Lumora, a UK based patented molecular technology company for approx. USD 41.6 million
- Visterra, US & Serum Institute, India announces license agreement for a humanized monoclonal antibody.Deal value approx. USD 40 million excluding royalties.
- Serum Institute in talks with PE firms to offer 10% stake at a valuation of USD12 billion.
- Sun Pharma bids to acquire InSite Vision Inc. USA for approx. USD 50 million
- India based Jubilant's subsidiary DraxImage signs pact with Cyclopharm to market Technegas in US. DraxImage will provide up to $4.5M USD to fund the USFDA clinical trial , and also pay 17.5% royalty.
- UK based Actis Capital to buy minority stake in India based Concord Biotech with an enterprise value of USD 227 million.
- India's Vidhi Research to buy Pfizer's Thane Plant in India for approx. US $30 million.
- Innovus Pharma Signs Exclusive $2.6 Million Dollar Marketing and Distribution Agreement with Khandelwal Laboratories to Market and Distribute Zestra(R) EjectDelay(R) Sensum+(R) and Zestra Glide(R) for the Indian Subcontinent.
- India based BPL Medical Technologies acquires UK based Penlon for expanding its presence in the critical care segment in 96 countries.
- US$20 Billion Pharma giant Abbott Co's board members, chairman hold global board meeting in India.
For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.
Aagami Updates:
- Client win for Aagami from a US based Technology Company Read More
- Another new assignment for Asia and Latin America from a Norway company with Innovative tools to improve mammalian cell-based expression systems Read More
- BIO Europe 2015, Munich, Germany - Aagami starts scheduling meetings
- Aagami Expert Speak: Great opportunity for India based Global companies: Latin America on Sale: Time to Go Pharma Shopping! Read More